Page last updated: 2024-10-26

ethosuximide and Lennox Gastaut Syndrome

ethosuximide has been researched along with Lennox Gastaut Syndrome in 2 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Lennox Gastaut Syndrome: A childhood-onset epilepsy syndrome.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hoshino, H1
Miya, F1
Kato, M1
Kanemura, H1
Brigo, F1
Striano, P1
Belcastro, V1

Reviews

1 review available for ethosuximide and Lennox Gastaut Syndrome

ArticleYear
A reappraisal of atypical absence seizures in children and adults: therapeutic implications.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:17

    Topics: Anticonvulsants; Epilepsy, Generalized; Ethosuximide; Humans; Lamotrigine; Lennox Gastaut Syndrome;

2019

Other Studies

1 other study available for ethosuximide and Lennox Gastaut Syndrome

ArticleYear
Efficacy of ethosuximide on atonic seizures with KCNB1 mutation.
    Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1

    Topics: Anticonvulsants; Child; Electroencephalography; Ethosuximide; Humans; Lennox Gastaut Syndrome; Male;

2022